Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,171,886
  • Shares Outstanding, K 110,218
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 18.33
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 73.39% ( -20.03%)
  • Historical Volatility 70.91%
  • IV Percentile 12%
  • IV Rank 31.21%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.52
  • Today's Volume 15,981
  • Volume Avg (30-Day) 22,739
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 156,793
  • Open Int (30-Day) 217,648

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.27
  • Number of Estimates 7
  • High Estimate -0.24
  • Low Estimate -0.32
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -8.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.64 +9.18%
on 04/19/24
89.10 -24.47%
on 03/26/24
-1.89 (-2.73%)
since 03/25/24
3-Month
20.92 +221.70%
on 01/26/24
99.41 -32.30%
on 02/28/24
+45.79 (+212.88%)
since 01/25/24
52-Week
8.28 +712.80%
on 10/26/23
99.41 -32.30%
on 02/28/24
+47.42 (+238.53%)
since 04/25/23

Most Recent Stories

More News
3 Millionaire-Maker Biotech Stocks

The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.

IOVA : 11.41 (-2.56%)
RXRX : 7.71 (-2.90%)
VKTX : 66.97 (+2.92%)
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

CRSP : 53.26 (-4.29%)
LLY : 724.14 (-1.10%)
NVO : 124.81 (-1.07%)
VRTX : 398.08 (-0.67%)
VKTX : 66.97 (+2.92%)
Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

LLY : 724.14 (-1.10%)
NVO : 124.81 (-1.07%)
NVDA : 824.02 (+3.42%)
AMGN : 268.49 (-1.66%)
PFE : 25.32 (-3.62%)
VKTX : 66.97 (+2.92%)
1 No-Brainer Vanguard Fund to Buy Right Now

This Vanguard growth fund is home to some of the world's most innovative companies.

VOO : 460.78 (-0.80%)
META : 436.36 (-11.58%)
MSFT : 395.34 (-3.35%)
AAPL : 169.03 (+0.01%)
AMZN : 172.18 (-2.50%)
NVDA : 824.02 (+3.42%)
AMGN : 268.49 (-1.66%)
ADBE : 471.86 (-1.10%)
VKTX : 66.97 (+2.92%)
PFE : 25.32 (-3.62%)
ANET : 266.66 (+4.67%)
PLTR : 21.41 (-0.83%)
3 Magnificent Stocks That Could Double or More by 2030

There's no guarantee these stocks will double by 2030, but their growth prospects look great.

CRSP : 53.26 (-4.29%)
LLY : 724.14 (-1.10%)
VKTX : 66.97 (+2.92%)
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics

These rising drugmakers have serious arguments in their favor.

CRSP : 53.26 (-4.29%)
VKTX : 66.97 (+2.92%)
VRTX : 398.08 (-0.67%)
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.

Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.

VKTX : 66.97 (+2.92%)
LLY : 724.14 (-1.10%)
PFE : 25.32 (-3.62%)
ALT : 7.10 (+0.28%)
This Small-Cap Biotech Could Gain Over 165%, Says Wall Street

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to combat obesity. Is TERN stock a good buy right now?

TERN : 4.53 (-4.63%)
VKTX : 66.97 (+2.92%)
LLY : 724.14 (-1.10%)
NVO : 124.81 (-1.07%)
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.

Shares of the clinical-stage biotech have skyrocketed on recent good news.

NVO : 124.81 (-1.07%)
LLY : 724.14 (-1.10%)
GS : 417.27 (-1.36%)
VKTX : 66.97 (+2.92%)
Is it Too Late to Buy Viking Therapeutics Stock?

Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate.

LLY : 724.14 (-1.10%)
VKTX : 66.97 (+2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 70.44
2nd Resistance Point 69.11
1st Resistance Point 67.09
Last Price 66.92
1st Support Level 63.74
2nd Support Level 62.41
3rd Support Level 60.39

See More

52-Week High 99.41
Last Price 66.92
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar